Back
Windtree Therapeutics Vs. ANI Pharmaceuticals Industry Stock Comparison
Sell
27
WINT
Windtree Therapeutics
Last Price:
0.49
Seasonality Move:
-4.03%
Sell
41
ANIP
ANI Pharmaceuticals
Last Price:
58.94
Seasonality Move:
5.08%
Sell
27
Windtree Therapeutics (WINT)
is a Sell
Is Windtree Therapeutics a Buy, Sell or Hold?
- The current Windtree Therapeutics [WINT] share price is $0.53. The Score for WINT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- WINT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
ANI Pharmaceuticals (ANIP)
is a Sell
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $59.87. The Score for ANIP is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- ANIP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
WINT Stock Price Chart
What is Windtree Therapeutics's stock price today?
-
The Windtree Therapeutics share price today is $0.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WINT is experiencing selling pressure, which indicates risk of future bearish movement.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $59.87
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ANIP is experiencing selling pressure, which indicates risk of future bearish movement.
WINT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.4 | Sell |
| Relative Strength Index (14 RSI): | 26.02 | Sell |
| Chaikin Money Flow: | -363752 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.61 - 0.87) | Sell |
| Bollinger Bands (100): | (0.61 - 7.97) | Sell |
ANIP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.46 | Buy |
| Relative Strength Index (14 RSI): | 53.14 | Buy |
| Chaikin Money Flow: | -344189 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.1 - 60.3) | Buy |
| Bollinger Bands (100): | (57.75 - 62.97) | Sell |
WINT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.61 | Sell |
| 20-day SMA: | 0.75 | Sell |
| 50-day SMA: | 1.69 | Sell |
| 200-day SMA: | 4.93 | Sell |
| 8-day EMA: | 0.61 | Sell |
| 20-day EMA: | 0.84 | Sell |
| 50-day EMA: | 2.07 | Sell |
| 200-day EMA: | 11.4 | Sell |
ANIP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.33 | Buy |
| 20-day SMA: | 59.07 | Buy |
| 50-day SMA: | 58.58 | Buy |
| 200-day SMA: | 62.13 | Sell |
| 8-day EMA: | 59.85 | Buy |
| 20-day EMA: | 59.13 | Buy |
| 50-day EMA: | 59.2 | Buy |
| 200-day EMA: | 59.91 | Sell |
Windtree Therapeutics Earnings Growth & WINT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $92.48 per share, and an increase next year of $0.25 per share.
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.49 per share.
Windtree Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ANI Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||